vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and HECLA MINING CO (HL). Click either name above to swap in a different company.

HECLA MINING CO is the larger business by last-quarter revenue ($448.1M vs $284.0M, roughly 1.6× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 30.0%, a 66.3% gap on every dollar of revenue. On growth, HECLA MINING CO posted the faster year-over-year revenue change (79.5% vs 9.4%). Over the past eight quarters, HECLA MINING CO's revenue compounded faster (53.8% CAGR vs 17.5%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Hecla Mining is a leading U.S.-based precious and base metals mining firm. Core products include silver, gold, lead and zinc, with operating assets across North America. It supplies raw materials to global jewelry manufacturing, industrial production, and renewable energy segments, and is a top domestic primary silver producer.

ACAD vs HL — Head-to-Head

Bigger by revenue
HL
HL
1.6× larger
HL
$448.1M
$284.0M
ACAD
Growing faster (revenue YoY)
HL
HL
+70.1% gap
HL
79.5%
9.4%
ACAD
Higher net margin
ACAD
ACAD
66.3% more per $
ACAD
96.3%
30.0%
HL
Faster 2-yr revenue CAGR
HL
HL
Annualised
HL
53.8%
17.5%
ACAD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
HL
HL
Revenue
$284.0M
$448.1M
Net Profit
$273.6M
$134.4M
Gross Margin
90.8%
55.4%
Operating Margin
6.1%
49.1%
Net Margin
96.3%
30.0%
Revenue YoY
9.4%
79.5%
Net Profit YoY
90.3%
1027.2%
EPS (diluted)
$1.61
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
HL
HL
Q4 25
$284.0M
$448.1M
Q3 25
$278.6M
$409.5M
Q2 25
$264.6M
$304.0M
Q1 25
$244.3M
$261.3M
Q4 24
$259.6M
$249.7M
Q3 24
$250.4M
$245.1M
Q2 24
$242.0M
$245.7M
Q1 24
$205.8M
$189.5M
Net Profit
ACAD
ACAD
HL
HL
Q4 25
$273.6M
$134.4M
Q3 25
$71.8M
$100.7M
Q2 25
$26.7M
$57.7M
Q1 25
$19.0M
$28.9M
Q4 24
$143.7M
$11.9M
Q3 24
$32.8M
$1.8M
Q2 24
$33.4M
$27.9M
Q1 24
$16.6M
$-5.8M
Gross Margin
ACAD
ACAD
HL
HL
Q4 25
90.8%
55.4%
Q3 25
92.2%
44.1%
Q2 25
92.2%
39.3%
Q1 25
91.7%
28.3%
Q4 24
91.6%
27.4%
Q3 24
92.5%
24.2%
Q2 24
92.5%
20.9%
Q1 24
88.8%
10.1%
Operating Margin
ACAD
ACAD
HL
HL
Q4 25
6.1%
49.1%
Q3 25
12.8%
36.3%
Q2 25
12.2%
30.8%
Q1 25
7.9%
20.0%
Q4 24
59.1%
15.3%
Q3 24
12.6%
9.2%
Q2 24
12.6%
16.5%
Q1 24
7.4%
2.7%
Net Margin
ACAD
ACAD
HL
HL
Q4 25
96.3%
30.0%
Q3 25
25.8%
24.6%
Q2 25
10.1%
19.0%
Q1 25
7.8%
11.0%
Q4 24
55.4%
4.8%
Q3 24
13.1%
0.7%
Q2 24
13.8%
11.3%
Q1 24
8.0%
-3.0%
EPS (diluted)
ACAD
ACAD
HL
HL
Q4 25
$1.61
$0.20
Q3 25
$0.42
$0.15
Q2 25
$0.16
$0.09
Q1 25
$0.11
$0.05
Q4 24
$0.86
$0.03
Q3 24
$0.20
$0.00
Q2 24
$0.20
$0.04
Q1 24
$0.10
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
HL
HL
Cash + ST InvestmentsLiquidity on hand
$177.7M
$301.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$2.6B
Total Assets
$1.6B
$3.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
HL
HL
Q4 25
$177.7M
$301.2M
Q3 25
$258.0M
$133.9M
Q2 25
$253.6M
$296.6M
Q1 25
$217.7M
$23.7M
Q4 24
$319.6M
$26.9M
Q3 24
$155.1M
$22.3M
Q2 24
$177.1M
$24.6M
Q1 24
$204.7M
$80.2M
Stockholders' Equity
ACAD
ACAD
HL
HL
Q4 25
$1.2B
$2.6B
Q3 25
$917.3M
$2.4B
Q2 25
$822.4M
$2.3B
Q1 25
$765.2M
$2.1B
Q4 24
$732.8M
$2.0B
Q3 24
$577.2M
$2.0B
Q2 24
$516.7M
$2.0B
Q1 24
$464.0M
$2.0B
Total Assets
ACAD
ACAD
HL
HL
Q4 25
$1.6B
$3.6B
Q3 25
$1.3B
$3.2B
Q2 25
$1.2B
$3.3B
Q1 25
$1.1B
$3.0B
Q4 24
$1.2B
$3.0B
Q3 24
$976.9M
$3.0B
Q2 24
$914.1M
$2.9B
Q1 24
$855.1M
$3.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
HL
HL
Operating Cash FlowLast quarter
$-48.7M
$217.1M
Free Cash FlowOCF − Capex
$134.7M
FCF MarginFCF / Revenue
30.1%
Capex IntensityCapex / Revenue
18.4%
Cash ConversionOCF / Net Profit
-0.18×
1.61×
TTM Free Cash FlowTrailing 4 quarters
$310.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
HL
HL
Q4 25
$-48.7M
$217.1M
Q3 25
$74.3M
$148.0M
Q2 25
$64.0M
$161.8M
Q1 25
$20.3M
$35.7M
Q4 24
$40.4M
$67.5M
Q3 24
$63.2M
$55.0M
Q2 24
$25.0M
$78.7M
Q1 24
$29.1M
$17.1M
Free Cash Flow
ACAD
ACAD
HL
HL
Q4 25
$134.7M
Q3 25
$73.9M
$90.1M
Q2 25
$103.8M
Q1 25
$-18.4M
Q4 24
$6.7M
Q3 24
$63.2M
$-690.0K
Q2 24
$28.3M
Q1 24
$-30.5M
FCF Margin
ACAD
ACAD
HL
HL
Q4 25
30.1%
Q3 25
26.5%
22.0%
Q2 25
34.1%
Q1 25
-7.0%
Q4 24
2.7%
Q3 24
25.2%
-0.3%
Q2 24
11.5%
Q1 24
-16.1%
Capex Intensity
ACAD
ACAD
HL
HL
Q4 25
18.4%
Q3 25
0.1%
14.1%
Q2 25
19.1%
Q1 25
20.7%
Q4 24
24.3%
Q3 24
0.0%
22.7%
Q2 24
20.5%
Q1 24
25.1%
Cash Conversion
ACAD
ACAD
HL
HL
Q4 25
-0.18×
1.61×
Q3 25
1.03×
1.47×
Q2 25
2.40×
2.80×
Q1 25
1.07×
1.24×
Q4 24
0.28×
5.66×
Q3 24
1.93×
31.24×
Q2 24
0.75×
2.82×
Q1 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

HL
HL

Silver Contracts$258.5M58%
Gold$129.2M29%
Zinc$30.3M7%
Lead$23.3M5%
Environmental Remediation Services$9.2M2%

Related Comparisons